Caliper Collaborates with DiscoveRx to Offer GPCR Assays on LabChip | GenomeWeb
NEW YORK (GenomeWeb News) – Caliper Life Sciences said today it has struck a collaboration agreement under which it will bundle its LabChip systems with DiscoveRx’s G-protein-coupled receptor assays for drug research. 
 
The Hopkinton, Mass.-based company said the combined offering includes DiscoveRx’s PathHunter Beta Arrestin and cAMP Hunter assays.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.